Restore Bio

Company

A company co-founded by Joan Mannick, focused on drug development involving TOR (Target of Rapamycin).

Mentioned in 2 videos

Videos Mentioning Restore Bio

#123–Joan Mannick & Nir Barzilai: Rapamycin and metformin—longevity, immune enhancement, & COVID-19

#123–Joan Mannick & Nir Barzilai: Rapamycin and metformin—longevity, immune enhancement, & COVID-19

Peter Attia MD

A company co-founded by Joan Mannick, focused on drug development involving TOR (Target of Rapamycin).

#118 – Lloyd Klickstein, M.D., Ph.D.: Rapamycin, mTOR inhibition, and the biology of aging

#118 – Lloyd Klickstein, M.D., Ph.D.: Rapamycin, mTOR inhibition, and the biology of aging

Peter Attia MD

A clinical-stage biopharmaceutical company focused on developing medicines that target mTOR inhibition. Lloyd Klickstein is their Chief Scientific Officer.